Globally, all pharmaceutical companies face the same challenge of finding effective drug targets that will translate into higher drug approval rates. Hyperdrive Science technology increases the accuracy of, and cuts the time required for, drug candidate selection, reducing the costs of drug development. The technology takes advantage of naturally occurring processes that allow genomic information from a cell to be translated into its corresponding protein library to be tested for new and emergent drug targets. Hyperdrive Science has been supported by the ON Accelerate program at CSIRO. http://www.oninnovation.com.au/en/ON-teams/ON-Tribe/ON-Accelerate4-Teams/Hyperdrive